Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tamas Gonda

Gastroenterology New York, NY Medical Doctor

NPI 1275783284 CMS profile 102906

240 E 38Th St Fl 23, New York, NY 10016

Open in the dashboard

General payments

$45,949

188 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$72,483 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Tamas Gonda of New York, NY is reported in the CMS Open Payments database as having received $45,949 across 188 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $72,483 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,959 16
2024 General $537 9
2023 General $1,016 10
2022 General $14,436 31
2021 General $11,327 32
2020 General $3,509 25
2019 General $12,165 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tamas Gonda
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Tamas Gonda were reported at $2,959. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Tamas Gonda Gastroenterology median Middle half National median
2019 $12,165 $417 $126–$1,100 $163
2020 $3,509 $224 $74–$624 $114
2021 $11,327 $352 $106–$1,054 $132
2022 $14,436 $448 $129–$1,270 $149
2023 $1,016 $533 $150–$1,390 $160
2024 $537 $605 $160–$1,606 $164
2025 $2,959 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $22,519 41 payments
  2. Wilson Cook Medical Incorporated $15,573 11 payments
  3. Alcresta Therapeutics, Inc. $2,000 1 payment
  4. Cook Medical LLC $1,792 52 payments
  5. AbbVie, Inc. $646 17 payments
  6. FUJIFILM Medical Systems USA, Inc. $597 4 payments
  7. Olympus America Inc. $542 13 payments
  8. Mauna Kea Technologies, Inc. $532 3 payments
  9. PENTAX of America, Inc. $218 3 payments
  10. Medtronic, Inc. $191 2 payments
  11. Other $1,338 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,250 6 payments
  2. Consulting Fee $12,450 8 payments
  3. Food and Beverage $6,051 153 payments
  4. Education $5,713 3 payments
  5. Travel and Lodging $3,386 16 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,600 1 payment
  7. Grant $500 1 payment
Products named General payments · program years 2019–2025
  1. Acquire $13,117 13 payments
  2. Cook Medical Hemospray $8,148 12 payments
  3. GENERAL BILIARY DEVICES $6,469 9 payments
  4. Cook Medical Endoscopic Ultrasound $5,205 9 payments
  5. Instinct $2,750 1 payment
  6. RELIZORB $2,000 1 payment
  7. GENERAL - THERAPIES $2,000 1 payment
  8. FUJIFILM $597 4 payments
  9. CREON $256 9 payments
  10. CONMED BILIARY $205 4 payments
  11. Other $4,119 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

38

Median for Gastroenterology: 569

Drug cost

$212

Median for Gastroenterology: $104,976

Branded share of claims

0%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Omeprazole Generic 26 $165
Pantoprazole Sodium Generic 12 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$136,723

Medicare's payments for the services billed

Medicare patients

551

Average age 74

Services billed

1,096

295 women, 256 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 51%
Ischemic heart disease 43%
Diabetes 39%
Cancer 28%
Chronic kidney disease 26%
Osteoporosis 26%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

188 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record